News

Columbus, Ohio. September 22, 2022. HDO Health announced today the appointment of Mr. Andrew Cothrel to their Board of Directors.

“We are thrilled to add a leader of Andrew’s caliber and experience to our Board. His alignment with our core values and deep experience and network in the segment will pay huge dividends for us as we enter the market and accelerate our growth,” said Bryan Stewart, Founder and CEO of HDO Health.

Andrew Cothrel is President of Rushlight Ventures, focused on monetizing the IP of small to mid-sized aerospace & defense firms and spinning up and curating commercially oriented new companies leveraging de-risked technology portfolios. He is also a founder, investor, and board member for several early-stage companies.

Before Rushlight, he founded Blue Marble Medical, spending 13 years developing and commercializing medical/health technologies and consulting in strategy, M&A, and new product development & commercialization, from both BigCo and Startup perspectives. He has led seven startups, transacted four exits, and raised more than $60MM at various early-stage companies in multiple roles.

His initial 20-year corporate career spanned progressively responsible roles at Exxon, Abbott Labs, and Roche, where he ended his BigCo days as VP/Site Manager of Roche’s life sciences research business area and as a corporate officer for Roche’s North American operating entity. His academic background includes a BS and MS in mechanical engineering complemented by business education at the University of Michigan, Cranfield University, and the London Business School. He resides in Oakwood, OH.

“I am excited to be joining the HDO Health team in a governance role - they have done a terrific job of developing a superior technology, and as the company moves into its next phase, I look forward to helping to bring this technology to patients who need it.,” said Mr. Cothrel.

Point of Contact: Bryan J. Stewart | Chief Executive Officer | 904.416.65656 | bstewart@hdohealth.com

May 5, 2022 - HDO Health is excited to announce participation in the 2022 Spring Ohio State Technology Showcase hosted by the Keenan Center for Entrepreneurship on Thursday May 19, 2022 from 5 - 7 pm EST at the Idea Foundry, 421 W. State Street, Columbus, OH 43215.

The event is to highlight the brilliant researchers who are discovering and creating exciting commercially viable technologies at The Ohio State University. HDO Health will be sharing about our technology, our innovative junctional tourniquet (The Journiquet) designed to help save the lives of individuals who have suffered a traumatic junctional wound. This technology is a past recipient of funding from the Ohio State Accelerator Awards, a program that is funded by The Ohio State University and the State of Ohio’s Department of Development and led by one of the HDO Health co-founders and current Vice President of Research and Development, Tanya Nocera, Ph.D.

The Accelerator Awards at Ohio State is a program that provides funding for technology development designed to accelerate the advancement of cutting-edge Ohio State innovations from the university into the marketplace. The program is funded by Ohio State, Ohio Third Frontier Technology Validation and Start-up Fund. The Keenan Center for Entrepreneurship administers the program at Ohio State. Since the program's launch in 2015, the Accelerator Awards have distributed over $5 million dollars to 69 unique projects. These projects have led over 20 startup companies.

Point of Contact: Bryan J. Stewart | Chief Executive Officer | 904.416.65656 | bstewart@hdohealth.com

March 18, 2022 - HDO Health is excited to announce its selection as a participant company for the 2022 Cohort of The Ohio State University Keenan Center for Entrepreneurship Wheeler and Wolstein Internship Program.

The Wheeler & Wolstein Internship Program provides scholarship funding to undergraduate and graduate students in internships with startup companies and small businesses. The program matches students with organizations offering a project-based internship during the summer term (May-August). Selected students receive a $7,000 scholarship to cover a living stipend during the summer term. There is no financial cost to participating organizations.

HDO Health is proud to have Olivia (Vick) Hillrich join our team for the summer. Three of the HDO Health co-founders are The Ohio State University alums and we are so grateful for this opportunity to "pay it forward" to another Buckeye as we complete important work to get our innovate junctional tourniquet (The Journiquet) cleared by the FDA and available for commercial release to help save the lives of individuals who have suffered a traumatic junctional wound.

Point of Contact: Bryan J. Stewart | Chief Executive Officer | 904.416.65656 | bstewart@hdohealth.com

March 15, 2022 - HDO Health was recently awarded a Technology Validation and Startup Fund (TVSF) Phase 2 Grant from Ohio Third Frontier. Ohio Third Frontier is an internationally recognized, technology-based economic development initiative that is successfully changing the trajectory of Ohio’s economy. Third Frontier works with innovative startup companies across the state, making Ohio the destination for technology entrepreneurs. This robust network of resources helps take advanced ideas and turn them into new technology businesses.

HDO Health will be utilizing the non-dilutive grant funds to further develop and finalize the design for their innovative junctional tourniquet (The Journiquet™) and prepare for a Class II U.S. Federal Drug Administration (FDA) 510(k) filing and clearance as well as other company infrastructure and commercialization activities.

Point of Contact: Bryan J. Stewart | Chief Executive Officer | 904.416.65656 | bstewart@hdohealth.com

June 29, 2021 - HDO Health is proud to announce that they have been selected for an initial engagement as part of the Rev1 Ventures startup studio. Rev1 Ventures is a unique investor startup studio that helps startups scale and corporates innovate. This engagement includes the pairing of the HDO Health founding team with a team of start-up advisors. In addition, it provides free access to significant learning resources, service providers, and a network of other entrepreneurs leading high-growth companies. This strategic partnership connects HDO Health to the talent, customers, space, and funding we need — when we need it.

Point of Contact: Bryan J. Stewart | Chief Executive Officer | 904.416.65656 | bstewart@hdohealth.com

March 18, 2022 - HDO Health was recently featured on the Rev1 Ventures blog. Click here to view on the Rev1 Ventures website.

HDO Health, a medical device startup based in Columbus, OH, is all about saving lives.

HDO Health’s Junctional Tourniquet (‘the Journiquet”), a class II medical device, innovates on current junctional tourniquet options. Its innovative design creates a tourniquet that stops bleeding faster. That’s because the Journiquet is easier for emergency responders and medical professionals to use and is more compact and portable at a more affordable price than existing junctional tourniquets.

HDO Health is developing and commercializing the Journiquet in partnership with The Ohio State University and the OSU Innovation Foundation (OSIF). Provisional and non-provisional patents have been filed and issued.

Point of Contact: Bryan J. Stewart | Chief Executive Officer | 904.416.65656 | bstewart@hdohealth.com

May 13, 2021 - The HDO Health team recently completed a TVSF Phase 1 funding and development cycle. The goal of the TVSF Phase 1 was to advance the design and fabricate functional prototypes in preparation for future demonstrations and operational testing of the HDO Health junctional tourniquet (the Journiquet). The objectives were to take the design through Technology Readiness Level (TRL) 6 with a system prototype demonstrated in a laboratory environment on a medical manikin with experienced users. The project results included capturing and documenting user requirements for a minimally viable product (MVP), fabrication of mock-ups of the preliminary design to support usability sessions conducted with military and EMT personnel to gather user inputs on requirements and product design. Using the outputs of the usability sessions, along with the generation of a design specification traceability matrix, a detailed engineering design of the device to include ergonomic and anthropometric design factors was completed. This work led to the fabrication of fully functional engineering prototypes for laboratory bench-top testing and a second usability session. Feedback from the second usability session conducted at the Ohio State University Clinical Skills Education and Assessment Center (CSEAC) informed the development of a comprehensive user requirements document and production of (v2) functional prototypes ready for perfused cadaver studies and other testing required for a FDA 510(k) submission.

Point of Contact: Bryan J. Stewart | Chief Executive Officer | 904.416.65656 | bstewart@hdohealth.com

HDO Health Recognized by Just Funded as One of the 45 Most Promising Law Enforcement Startups with Seed Funding

October 7, 2022 - HDO Health was recognized by Just Funded as one of the 45 Most Promising Law Enforcement Startups with Seed Funding in the United States. Check out the full article here.

Point of Contact: Bryan J. Stewart | Chief Executive Officer | 904.416.65656 | bstewart@hdohealth.com